Latest News and Press Releases

New York City, April 21, 2025 (GLOBE NEWSWIRE) -- Introduction  Managing blood sugar is a challenge that many individuals face daily. Whether it’s due to lifestyle factors, diet choices, or...

Icovamenib & BMF-650 (oral small molecule GLP-1) are the cornerstones of the metabolic franchiseBiomea preparing icovamenib for late-stage clinical development2025 corporate update to be presented...

Inflammasome-driven inflammation in obesity results in severely damaged pancreatic islets, leading to islet cell loss and metabolic dysfunction.

Selbyville, Delaware, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Prediabetes Market size is estimated to reach USD 360.6 million by the end of 2032. The industry growth is driven by the increasing global...

NLRP3-Mediated Inflammation in Obese Children Leads to Insulin Resistance and Risk of Complications (e.g., Type 2 Diabetes, Hypertension, Heart Disease).

New York, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The global Cardiometabolic Drugs Market size is projected to expand at ~ 6% CAGR between 2023 and 2035. The market is expected to garner a revenue of USD...

Selbyville, Delaware, June 13, 2023 (GLOBE NEWSWIRE) -- GLP-1 Receptor Agonist Market size is estimated to amass USD 55.8 billion by 2032. The industry is set to observe notable growth driven...